Cargando…
Salidroside suppresses the multiple oncogenic activates and immune escape of lung adenocarcinoma through the circ_0009624‐mediated PD‐L1 pathway
BACKGROUND: Lung adenocarcinoma (LUAD) is a fatal malignancy all over the world. Salidroside (SAL) is an active component extracted from Rhodiola rosea that has been reported to exert antitumor activity against several human cancers, containing lung adenocarcinoma (LUAD). The purpose of this study w...
Autores principales: | Jin, Guilin, Ma, Mi, Yang, Chunyan, Zhen, Luo, Feng, Mingke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10447170/ https://www.ncbi.nlm.nih.gov/pubmed/37423604 http://dx.doi.org/10.1111/1759-7714.15034 |
Ejemplares similares
-
Assessment of the alleviating effects of salidroside on myocardial function and perfusion impairment in rats with sepsis: Effects of salidroside on myocardial function and perfusion impairment
por: Qin, Wenjuan, et al.
Publicado: (2023) -
B4GALT1 promotes immune escape by regulating the expression of PD-L1 at multiple levels in lung adenocarcinoma
por: Cui, Yanan, et al.
Publicado: (2023) -
Antihypothyroid Effect of Salidroside
por: Korbozova, Nazym K., et al.
Publicado: (2022) -
The Metabolism of Salidroside to Its Aglycone p-Tyrosol in Rats following the Administration of Salidroside
por: Guo, Na, et al.
Publicado: (2014) -
MTDH is an oncogene in multiple myeloma, which is suppressed by Bortezomib treatment
por: Gu, Chunyan, et al.
Publicado: (2015)